ArticlePharmaceutics2024

Targeted Delivery of STING Agonist via Albumin Nanoreactor Boosts Immunotherapeutic Efficacy against Aggressive Cancers.

Zhijun Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.